AXIM BIOTECHNOLOGIES, INC. Derivative Liability
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Derivative Liability of $4.12 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2024-08-19
- 2024-06-30: Derivative Liability $4.12M.
- 2024-03-31: Derivative Liability $2.49M.
- 2023-12-31: Derivative Liability $2.48M.
- 2023-09-30: Derivative Liability $2.37M.
| Period end | Derivative Liability |
|---|---|
| 2024-06-30 | $4.12M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $2.49M 10-Q/A · filed 2024-05-22 |
| 2023-12-31 | $2.48M 10-Q · filed 2024-08-19 |
| 2023-09-30 | $2.37M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $2.98M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $1.12M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $1.65M 10-K · filed 2024-04-16 |
| 2022-09-30 | $2.00M 10-Q · filed 2023-11-20 |
| 2022-06-30 | $1.72M 10-Q · filed 2023-08-21 |
| 2022-03-31 | $2.05M 10-Q · filed 2023-11-20 |
| 2021-12-31 | $0.00 10-K · filed 2024-04-16 |